Latest News

Chemo-radionuclide therapy halts neuroendocrine cancer

Advanced cancer of the neuroendocrine system can lead to dismal prognoses, but a novel therapy is packing a punch by uniting powerful radionuclide treatment and chemotherapy drugs, revealed researchers. Neuroendocrine tumors (NETs) are those that develop within a multiplicity of organs throughout the body that have nerve cells and interact with the endocrine system through chemical signaling made possible with various hormones. These tumors usually develop along the intestines and lungs, but they can also be found in the pancreas and many other sites.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Mental Health: New approach 'has positive impact'

  • Extracurricular sports produce disciplined preteens

  • 70 percent of college students stressed about finances

  • Novel DNA repair mechanism brings new horizons

  • REM sleep critical for young brain development; medication interferes

  • How the stress hormone cortisol reinforces traumatic memories

  • Documenting how dementia sufferers benefit from GPS

  • Prion trials and tribulations: Finding the right tools and experimental models

  • Puccini?s ?exotic inspiration?:Unusual source of Madam Butterfly's melodies revealed

  • Online reader comments can provide valuable feedback to news sites

  •